Abstract
Hyperthermic treatment of cancer by magnetic nanoparticles has shown promising results in recent years. Magnetic nanoparticles in the form of stable fluids can be transported to the effected cells noninvasively through a variety of drug delivery routes. Upon stimulation by a radio frequency magnetic field, these nanoparticles induce local heat remotely, which causes the temperature in organs and tissues containing tumoral cells to rise and causes the death of infected cells. The heat generation mainly results from three independent physical mechanisms, Néel relaxation, Brownian relaxation, and hysteresis loss. The involvement of each mechanism firmly depends on the crystal size, crystal structure, morphology, and degree of aggregation of the nanoparticles. Nanostructures based on iron oxide and its relevant ferrites, such as cobalt ferrite and nickel ferrite, in a range of a few nanometers, showing superparamagnetic properties have been investigated extensively for magnetic hyperthermia. This chapter will cover different aspects of magnetic hyperthermia from a material science point of view, including mechanisms, materials, crystal size, shape, the effect of architecture on heat generation efficiency, and practical procedures to measure the therapeutic properties of fluidic nanoparticles preinjection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Caster JM, Patel AN, Zhang T, Wang A (2016) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (In press)
Del Burgo LS, Hernãindez RM, Orive G, Pedraz JL (2014) Nanotherapeutic approaches for brain cancer management. Nanomedicine: Nanotechnology, Biology and Medicine 10: e905–e919
De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133
Deatsch AE, Evans BA (2014) Heating efficiency in magnetic nanoparticle hyperthermia. J. Magn. Magn. Mater. 354:163–172
Deraco M, Kusamura S, Virzì S, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Iusco DR, Baratti D (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. Gynecol Oncol 122:215–220
Gobbo OL, Sjaastad K, Radomski MW, Volkov Y, Prina-Mello A (2015) Magnetic nanoparticles in cancer theranostics. Theranostics 5:1249
Casanovas O (2012) Cancer: Limitations of therapies exposed. Nature 484:44–46
Garattini S, Bertele V (2002) Efficacy, safety, and cost of new anticancer drugs. Br Med J 325:269
Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nat Med 7:987–989
Van der Seldt AA, Lubberink M, Bahce I, Walraven M, de Boer MP, Greuter HN, Hendrikse NH, Eriksson J, Windhorst AD, Postmus PE, Verheul HM, Serné EH, Lammertsma AA, Smit EF (2012) Rapid decrease in delivery of chemotherapy to tumors after Anti-VEGF therapy: Implications for scheduling of anti-angiogenic drugs. Cancer Cell 21:82–91
Sardari D, Verga N (2011) Cancer treatment with hyperthermia. In: Özdemir Ö (ed) Current cancer treatment-novel beyond conventional approaches. InTech, Istanbul, pp 455–475
Bush W (1886) Uber den Finfluss wetchen heftigere Eryspelen zuweilen auf organlsierte Neubildungen dusuben. Verh Natruch Preuss Rhein Westphal 23:28–30
Jordan A, Scholz R, Wust P, Fähling H, Felix R (1999) Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J. Magn. Magn. Mater. 201:413–419
Banobre-López M, Teijeiro A, Rivas J (2013) Magnetic nanoparticle-based hyperthermia for cancer treatment. Rep Practical Oncol Radiother 18:397–400
Chichel A, Skowronek J, Kubaszewska M, Kanikowski M (2007) Hyperthermia description of a method and a review of clinical applications. Rep Practical Oncol Radiother 12:267–275
Salunkhe AB, Khot VM, Pawar SH (2014) Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr Top Med Chem 14:572–594
Wust P, Nadobny J, Fahling H, Riess H, Koch K, John W, Felix R (1991) Determinant factors and disturbances in controlling power distribution patterns by the hyperthermia-ring system BSD-2000. 2. Measuring techniques and analysis. Strahlenther Onkol 167:172–180
Andreu I, Natividad E (2013) Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia. Int J Hyperthermia 29:739–751
Khushrushahi SR (2005) A quantitative design and analysis of magnetic nanoparticle heating systems. Massachusetts Institute of Technology, Cambridge, MA
Presman A (2013) Electromagnetic fields and life. Springer, Berlin
Cavaliere R, Giogatto BC, Giovanella BC (1967) Selective heat sensitivity of cancer cells. Cancer 20:1351–1381
Levine EM, Robbins EB (1970) Differential temperature sensitivity of normal and cancer cells in culture. J Cell Physiol 76:373–379
Diederich CJ (2005) Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthermia 21:745–753
Gneveckow U, Jordan A, Scholz R, Brüss V, Waldöfner N, Ricke J, Feussner A, Hildebrandt B, Rau B, Wust P (2004) Description and characterization of the novel hyperthermia-and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys 31:1444–1451
Dutz S, Hergt R (2013) Magnetic nanoparticle heating and heat transfer on a microscale: basic principles, realities and physical limitations of hyperthermia for tumour therapy. Int J Hyperthermia 29:790–800
Valdagni R, Amichetti M (1994) Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169
Abdeen S, Praseetha PK (2013) Diagnostics and treatment of metastatic cancers with magnetic nanoparticles. J Nanomedicine Biosci Discov 2013
Falk MH, Issels RD (2001) Hyperthermia in oncology. Int J Hyperthermia 17:1–18
Jia D, Liu J (2010) Current devices for high-performance whole-body hyperthermia therapy. Expert Rev Med Devices 7:407–423
Kim DH, Lee SH, Im KH, Kim KN, Kim KM, Shim IB, Lee MH, Lee YK (2006) Surface-modified magnetite nanoparticles for hyperthermia: Preparation, characterization, and cytotoxicity studies. Curr Appl Phys 6:e242–e246
Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB (1957) Selective inductive heating of lymph nodes. Ann Surg 146:596
Bai L-Z, Zhao D-L, Xu Y, Zhang J-M, Gao Y-L, Zhao L-Y, Tang J-T (2012) Inductive heating property of graphene oxide-Fe3O4 nanoparticles hybrid in an AC magnetic field for localized hyperthermia. Mater Lett 68:399–401
Behdadfar B, Kermanpur A, Sadeghi-Aliabadi H, Del Puerto Morales M, Mozaffari M (2012) Synthesis of aqueous ferrofluids of Zn x Fe3O4 nanoparticles by citric acid assisted hydrothermal-reduction route for magnetic hyperthermia applications. J. Magn. Magn. Mater. 324:2211–2217
Cantillon MP, Wald LL, Zahn M, Adalsteinsson E (2010) Proposing magnetic nanoparticle hyperthermia in low field MRI. Concepts in Magnetic Resonance Part A 36:36–47
Fathi Karkan S, Mohammadhosseini M, Panahi Y, Milani M, Zarghami N, Akbarzadeh A, Abasi E, Hosseini A, Davaran S (2016) Magnetic nanoparticles in cancer diagnosis and treatment: a review. Artif Cells Nanomed Biotechnol:1–5
Giustini AJ, Petryk AA, Cassim SM, Tate JA, Baker I, Hoopes PI (2010) Magnetic nanoparticle hyperthermia in cancer treatment. Nano Life 1:17–32
Goya GF, Grazu V, Ibarra MR (2008) Magnetic nanoparticles for cancer therapy. Current Nanoscience 4:1–16
Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1–11
Pankhurst QA, Connolly J, Jones SK, Dobson JJ (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:R167
Choi H, Choi SR, Zhou R, Kung HF, Chen IW (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996–1004
Peng X-H, Qian X, Mao H, Wang AY, Chen ZG, Nie S, Shin DM (2008) Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine 3:311–321
Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V (2008) Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29:4012–4021
Liu X, Chen Y, Li H, Huang N, Jin Q, Ren K, Ji J (2013) Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior. ACS Nano 7:6244–6257
Alonso J, Khurshid H, Devkota J, Nemati Z, Khadka NK, Srikanth H, Pan J, Phan M-H (2016) Superparamagnetic nanoparticles encapsulated in lipid vesicles for advanced magnetic hyperthermia and biodetection. J Appl Phys 119:083904
Cervadoro A, Giverso C, Pande R, Sarangi S, Preziosi L, Wosik J, Brazdeikis A, Decuzzi P (2013) Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS One 8:e57332
Haring M, Schiller J, Mayr J, Grijalvo S, Eritja R, Díaz DD (2015) Magnetic gel composites for hyperthermia cancer therapy. Gels 1:135–161
Hoopes PJ, Petryk AA, Gimi B, Giustini AJ, Weaver JB, Bischof J, Chamberlain R, Garwood M (2012) In vivo imaging and quantification of iron oxide nanoparticle uptake and biodistribution. In: SPIE Medical Imaging. International Society for Optics and Photonics, p 83170R-83170R-83179.
Stelter L, Pinkernelle JG, Michel R, Schwartlander R, Raschzok N, Morgul MH, Koch M, Denecke T, Ruf J, Baumler H (2010) Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3 T MRI, small animal PET, and fluorescence imaging. Mol Imaging Biol 12:25–34
Wust P, Gneveckow U, Johannsen M, Böhmer D, Henkel T, Kahmann F, Sehouli J, Felix R (2006) Magnetic nanoparticles for interstitial thermotherapyâ€feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22:673–685
Pöttler M, Staicu A, Zaloga J, Unterweger H, Weigel B, Schreiber E, Hofmann S, Wiest I, Jeschke U, Alexiou C (2015) Genotoxicity of superparamagnetic iron oxide nanoparticles in granulosa cells. Int J Mol Sci 16:26280–26290
Ahmed M, De Rosales RT, Douek M (2013) Preclinical studies of the role of iron oxide magnetic nanoparticles for nonpalpable lesion localization in breast cancer. J Surg Res 185:27–35
Sadhukha T, Wiedmann TS, Panyam J (2013) Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34:5163–5171
Taratula O, Dani RK, Schumann C, Xu H, Wang A, Song H, Dhagat P, Taratula O (2013) Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. Int J Pharm 458:169–180
Fortin J-P, Wilhelm C, Servais J, Ménager C, Bacri J-C, Gazeau F (2007) Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 129:2628–2635
Shreshtha PP, Mohite SS, Jadhav MGK (2015) Review on thermal seeds in magnetic hyperthermia therapy. IJITR 3:2283–2287
Hergt R, Andra W, D’ambly CG, Hilger I, Kaiser WA, Richter U, Schmidt HG (1998) Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn 34:3745–3754
Ramprasad R, Zurcher P, Petras M, Miller M, Renaud P (2004) Magnetic properties of metallic ferromagnetic nanoparticle composites. J Appl Phys 96:519–529
Rosensweig RE (2002) Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252:370–374
Andra W, Nowak H (2007) Magnetism in medicine: a handbook. Wiley, New York
Gubin SP, Koksharov YA, Khomutov GB, Yurkov GVE (2005) Magnetic nanoparticles: preparation, structure and properties. Russ Chem Rev 74:489–520
Burrows F, Parker C, Evans RFL, Hancock Y, Hovorka O, Chantrell RW (2010) Energy losses in interacting fine-particle magnetic composites. J Phys D Appl Phys 43:474010
Dennis CL, Jackson AJ, Borchers JA, Hoopes PJ, Strawbridge R, Foreman AR, Van Lierop J, Grüttner C, Ivkov R (2009) Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology 20:395103
Hergt R, Dutz S, Müller R, Zeisberger M (2006) Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J Phys Condens Matter 18:S2919
Hergt R, Dutz S, Röder M (2008) Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys Condens Matter 20:385214
Gittleman JI, Abeles B, Bozowski S (1974) Superparamagnetism and relaxation effects in granular Ni-SiO2 and Ni-Al2O3 films. Phys Rev B 9:3891
Jordan A, Wust P, Fähling H, John W, Hinz A, Felix R (2009) Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 25:499–511
Lu AH, Salabas EEL, Schüth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed 46:1222–1244
Kurti N (1988) Selected works of louis neel. CRC Press, Boca Raton, FL
Neel L (1950) Theorie du trainage magnetique des substances massives dans le domaine de Rayleigh. Journal de Physique et le Radium 11:49–61
Brown WF Jr (1963) Thermal fluctuations of a single domain particle. J Appl Phys 34: 1319–1320
Deissler RJ, Wu Y, Martens MA (2014) Dependence of brownian and neel relaxation times on magnetic field strength. Med Phys 41:012301
Lima E Jr, Torres TE, Rossi LM, Rechenberg HR, Berquo TS, Ibarra A, Marquina C, Ibarra MR, Goya GF (2013) Size dependence of the magnetic relaxation and specific power absorption in iron oxide nanoparticles. J Nanopart Res 15:1–11
Zhang X, Chen S, Wang H-M, Hsieh S-L, Wu C-H, Chou H-H, Hsieh S (2010) Role of neel and brownian relaxation mechanisms for water-based Fe3O4 nanoparticle ferrofluids in hyperthermia. Biomed Eng: Appl Basis Commun 22:393–399
Motoyama J, Hakata T, Kato R, Yamashita N, Morino T, Kobayashi T, Honda H (2010) Size dependent heat generation of magnetic nanoparticles under AC magnetic field for cancer therapy. In: Animal cell technology: Basic & applied aspects. Springer, pp 415–421
Guibert CM, Dupuis V, Peyre V, Fresnais JRM (2015) Hyperthermia of magnetic nanoparticles: experimental study of the role of aggregation. J Phys Chem C 119:28148–28154
Obaidat IM, Issa B, Haik Y (2015) Magnetic properties of magnetic nanoparticles for efficient hyperthermia. Nanomaterials 5:63–89
Thanh NTK (2012) Magnetic nanoparticles: from fabrication to clinical applications. CRC press, Boca Raton, FL
Yahya N (2011) Carbon and oxide nanostructures: synthesis, characterisation and applications. Springer, Berlin
Basti H, Hanini A, Levy M, Tahar LB, Herbst F, Smiri LS, Kacem K, Gavard J, Wilhelm C, Gazeau F (2014) Size tuned polyol-made Zn0. 9M0.1Fe2O4 (M=Mn, Co, Ni) ferrite nanoparticles as potential heating agents for magnetic hyperthermia: from synthesis control to toxicity survey. Mater Res Exp 1:045047
Beji Z, Hanini A, Smiri LS, Gavard J, Kacem K, Villain F, Grenèche JM, Chau F, Ammar S (2010) Magnetic properties of Zn-substituted MnFe2O4 nanoparticles synthesized in polyol as potential heating agents for hyperthermia. Evaluation of their toxicity on Endothelial cells. Chem Mater 22:5420–5429
Cespedes E, Byrne JM, Farrow N, Moise S, Coker VS, Bencsik M, Lloyd JR, Telling ND (2014) Bacterially synthesized ferrite nanoparticles for magnetic hyperthermia applications. Nanoscale 6:12958–12970
Hanini A, Lartigue L, Gavard J, Schmitt A, Kacem K, Wilhelm C, Gazeau F, Chau F, Ammar S (2016) Thermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following Î3-Fe2O3 NPs internalization and magnetic field application. RSC Advances 6:15415–15423
Lin M, Huang J, Sha M (2014) Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment. J Nanosci Nanotechnol 14:792–802
Veverka M, Zãvta K, Kaman O, Veverka P, Knížek K, Pollert E, Burian M, Kašpar P (2014) Magnetic heating by silica-coated Co-Zn ferrite particles. J Phys D Appl Phys 47:065503
Hanini A, Lartigue L, Gavard J, Kacem K, Wilhelm C, Gazeau F, Chau FO, Ammar S (2016) Zinc substituted ferrite nanoparticles with Zn0.9Fe2.1O4 formula used as heating agents for in vitro hyperthermia assay on glioma cells. J. Magn. Magn. Mater. 416:315–320
Wijaya A, Brown KA, Alper JD, Hamad-Schifferli K (2007) Magnetic field heating study of Fe-doped Au nanoparticles. J Magn Magn Mater 309:15–19
Hilger I, Kaiser WA (2012) Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 7:1443–1459
Neuberger T, Schöpf B, Hofmann H, Hofmann M, Von Rechenberg B (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293:483–496
Hiergeist R, Andrã W, Buske N, Hergt R, Hilger I, Richter U, Kaiser W (1999) Application of magnetite ferrofluids for hyperthermia. J Magn Magn Mater 201:420–422
Gonzales-Weimuller M, Zeisberger M, Krishnan KM (2009) Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J. Magn. Magn. Mater. 321: 1947–1950
Guardia P, Di Corato R, Lartigue L, Wilhelm C, Espinosa A, Garcia-Hernandez M, Gazeau F, Manna L, Pellegrino T (2012) Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6:3080–3091
Lartigue LN, Hugounenq P, Alloyeau D, Clarke SP, Lévy M, Bacri J-C, Bazzi R, Brougham DF, Wilhelm C, Gazeau F (2012) Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano 6:10935–10949
Kolosnjaj-Tabi J, Di Corato R, Lartigue LN, Marangon I, Guardia P, Silva AKA, Luciani N, Clément O, Flaud P, Singh JV (2014) Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment. ACS Nano 8:4268–4283
Di Corato R, Espinosa A, Lartigue L, Tharaud M, Chat S, Pellegrino T, Ménager C, Gazeau F, Wilhelm C (2014) Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials 35:6400–6411
Gandhi S, Arami H, Krishnan KM (2016) Detection of cancer-specific proteases using magnetic relaxation of peptide-conjugated nanoparticles in biological environment. Nano Lett
Lowry GV, Gregory KB, Apte SS, Lead JR (2012) Transformations of nanomaterials in the environment. Environ Sci Technol 46:6893–6899
Thomas CR, George S, Horst AM, Ji Z, Miller RJ, Peralta-Videa JR, Xia T, Pokhrel S, Maìdler L, Gardea-Torresdey JL (2011) Nanomaterials in the environment: from materials to high-throughput screening to organisms. ACS Nano 5:13–20
Levard C, Hotze EM, Lowry GV, Brown GE Jr (2012) Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Technol 46:6900–6914
Xia T, Zhao Y, Sager T, George S, Pokhrel S, Li N, Schoenfeld D, Meng H, Lin S, Wang X (2011) Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 5:1223–1235
Kolosnjaj-Tabi J, Lartigue LN, Javed Y, Luciani N, Pellegrino T, Wilhelm C, Alloyeau D, Gazeau F (2016) Biotransformations of magnetic nanoparticles in the body. Nano Today 11:280–284
Koksharov YA (2009) Magnetism of nanoparticles: Effects of size, shape, and interactions. In: Gubin SP (ed) Magnetic nanoparticles. Wiley-VCH, pp 197–254
Alloyeau D, Dachraoui W, Javed Y, Belkahla H, Wang G, Lecoq HLN, Ammar S, Ersen O, Wisnet A, Gazeau F (2015) Unravelling kinetic and thermodynamic effects on the growth of gold nanoplates by liquid transmission electron microscopy. Nano Lett 15:2574–2581
Laurent S, Dutz S, Häfeli UO, Mahmoudi M (2011) Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166:8–23
Chen D, Xu R (1998) Hydrothermal synthesis and characterization of nanocrystalline Fe3O4 powders. Mater Res Bull 33:1015–1021
Lawrence MJ, Rees GD (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
Titirici M-M, Antonietti M, Thomas A (2006) A generalized synthesis of metal oxide hollow spheres using a hydrothermal approach. Chem Mater 18:3808–3812
Cheng C, Xu F, Gu H (2011) Facile synthesis and morphology evolution of magnetic iron oxide nanoparticles in different polyol processes. New J Chem 35:1072–1079
Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110
Hoskins C, Min Y, Gueorguieva M, Mcdougall C, Volovick A, Prentice P, Wang Z, Melzer A, Cuschieri A, Wang L (2012) Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application. J Nanobiotechnol 10:1
Gao J, Gu H, Xu B (2009) Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 42:1097–1107
Salvador-Morales C, Gao W, Ghatalia P, Murshed F, Aizu W, Langer R, Farokhzad OC (2009) Multifunctional nanoparticles for prostate cancer therapy. Expert Rev Anticancer Ther 9: 211–221
Bergey EJ, Levy L, Wang X, Krebs LJ, Lal M, Kim K-S, Pakatchi S, Liebow C, Prasad PN (2002) DC magnetic field induced magnetocytolysis of cancer cells targeted by LH-RH magnetic nanoparticles in vitro. Biomed Microdevices 4:293–299
Berry CC, Curtis ASG (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 36:R198
Briley-Saebo KC, Johansson LO, Hustvedt SO, Haldorsen AG, Bjørnerud A, Fayad ZA, Ahlstrom HK (2006) Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest Radiol 41:560–571
Kolosnjaj-Tabi J, Javed Y, Lartigue LN, Volatron J, Elgrabli D, Marangon I, Pugliese G, Caron B, Figuerola A, Luciani N (2015) The one year fate of iron oxide coated gold nanoparticles in mice. ACS Nano 9:7925–7939
Levy M, Luciani N, Alloyeau D, Elgrabli D, Deveaux V, Pechoux C, Chat S, Wang G, Vats N, Gendron FO (2011) Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 32:3988–3999
Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) Protein nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610–5637
Sperling RA, Parak WJ (2010) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans R Soc Lond A: Math Phys Eng Sci 368: 1333–1383
Lazzari S, Moscatelli D, Codari F, Salmona M, Morbidelli M, Diomede L (2012) Colloidal stability of polymeric nanoparticles in biological fluids. J Nanopart Res 14:1–10
Ditto AJ, Shah KN, Robishaw NK, Panzner MJ, Youngs WJ, Yun YH (2012) The Interactions between l-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow. Mol Pharm 9:3089–3098
Kumar S, Aaron J, Sokolov K (2008) Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat Protoc 3:314–320
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021
Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ (2008) Biological applications of gold nanoparticles. Chem Soc Rev 37:1896–1908
Mohammad F, Balaji G, Weber A, Uppu RM, Kumar CSSR (2010) Influence of gold nanoshell on hyperthermia of superparamagnetic iron oxide nanoparticles. J Phys Chem C 114:19194–19201
Javed Y, Lartigue LN, Hugounenq P, Vuong QL, Gossuin Y, Bazzi R, Wilhelm C, Ricolleau C, Gazeau F, Alloyeau D (2014) Biodegradation mechanisms of iron oxide monocrystalline nanoflowers and tunable shield effect of gold coating. Small 10:3325–3337
Li S-D, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504
Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
Shilo M, Sharon A, Baranes K, Motiei M, Lellouche J-PM, Popovtzer R (2015) The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model. J Nanobiotechnol 13:1
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515
Czuprynski CJ (2016) Opsonization and Phagocytosis. Encyclopedia of Immunotoxicology: 674–676
Salmaso S, Caliceti P (2013) Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv 2013:19
Al-Hanbali O, Rutt KJ, Sarker DK, Hunter AC, Moghimi SM (2006) Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J Nanosci Nanotechnol 6:3126–3133
Jo DH, Kim JH, Lee TG, Kim JH (2015) Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomed: Nanotechnol, Biol Med 11:1603–1611
Frohlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577–5591
Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M (2013) Nanoparticle and protein corona. In: Protein-nanoparticle interactions. Springer, pp 21–44
Dell’orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S (2010) Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 5:e10949
Bargheer D, Nielsen J, Gébel G, Heine M, Salmen SC, Stauber R, Weller H, Heeren J, Nielsen P (2015) The fate of a designed protein corona on nanoparticles in vitro and in vivo. Beilstein J Nanotechnol 6:36–46
Foroozandeh P, Aziz AA (2015) Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett 10:1–12
Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150:552–558
Shang L, Nienhaus K, Nienhaus GU (2014) Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol 12:1
Cummings BS, Wills LP, Schnellmann RG (2012) Measurement of cell death in Mammalian cells. Current Protocols in Pharmacology 12.18. 11–12.18. 24.
Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, Dinda AK (2009) Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine 5:983–989
Ghosh R, Pradhan L, Devi YP, Meena SS, Tewari R, Kumar A, Sharma S, Gajbhiye NS, Vatsa RK, Pandey BN (2011) Induction heating studies of Fe3O4 magnetic nanoparticles capped with oleic acid and polyethylene glycol for hyperthermia. J Mater Chem 21:13388–13398
Ma M, Wu Y, Zhou J, Sun Y, Zhang Y, Gu N (2004) Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field. J. Magn. Magn. Mater. 268:33–39
Zhao D-L, Wang X-X, Zeng X-W, Xia Q-S, Tang J-T (2009) Preparation and inductive heating property of Fe3O4 chitosan composite nanoparticles in an AC magnetic field for localized hyperthermia. J Alloys Compd 477:739–743
Sadat ME, Patel R, Sookoor J, Bud’ko SL, Ewing RC, Zhang J, Xu H, Wang Y, Pauletti GM, Mast DB (2014) Effect of spatial confinement on magnetic hyperthermia via dipolar interactions in Fe3O4 nanoparticles for biomedical applications. Mater Sci Eng C 42:52–63
Kozissnik B, Bohorquez AC, Dobson J, Rinaldi C (2013) Magnetic fluid hyperthermia: Advances, challenges, and opportunity. Int J Hyperthermia 29:706–714
Fadeel B, Garcia-Bennett AE (2010) Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62:362–374
Kida Y, Ishiguri H, Ichimi K, Kobayashi T (1990) Hyperthermia of metastatic brain tumor with implant heating system: a preliminary clinical results. No shinkei geka. Neurol Surg 18:521–526
Kobayashi T, Kida Y, Matsui M, Amemiya Y (1990) Interstitial hyperthermia of malignant brain tumors using implant heating system (IHS). No shinkei geka. Neurol Surg 18:247–252
Luo S, Wang LF, Ding WJ, Wang H, Zhou JM, Jin HK, Su SF, Ouyang WW (2014) Clinical trials of magnetic induction hyperthermia for treatment of tumours. OA Cancer 2:2
Hentschel M, Mirtsch S, Jordan A, Wust P, Vogl TH, Semmler W, Wolf KJ, Felix R (1997) Heat response of HT29 cells depends strongly on perfusion–A 31P NMR spectroscopy, HPLC and cell survival analysis. Int J Hyperthermia 13:69–82
Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, Von Deimling A, Waldoefner N, Felix R (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53–60
Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 103:317–324
Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P (2007) Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 52:1653–1662
Gao F, Yan Z, Zhou J, Cai Y, Tang J (2012) Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor. J Nanopart Res 14:1–10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Javed, Y., Ali, K., Jamil, Y. (2017). Magnetic Nanoparticle-Based Hyperthermia for Cancer Treatment: Factors Affecting Heat Generation Efficiency. In: Sharma, S. (eds) Complex Magnetic Nanostructures. Springer, Cham. https://doi.org/10.1007/978-3-319-52087-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-52087-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52086-5
Online ISBN: 978-3-319-52087-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)